Search by Journal

  • HOME 
  •  >  Search by Journal
  •  >  Annual Meeting of Japanese Association of Cardiovascular Pharmacology

Annual Meeting of Japanese Association of Cardiovascular Pharmacology

Volume 33, Issue / 2024
English Article   Japanese Article
  • Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
Japanese Article In the 33rd Japan circulation Japanese Pharmacological Society academic meeting holding
高井真司
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 1-1, 2024.
Japanese Article We reconsider the drug of the circulatory organ domain in the aged society
星賀正明
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 14-14, 2024.
Japanese Article S-1. Elucidation of the new functional regulation mechanism of the G protein conjugate type receptor through the post-translational modification
西山和宏
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 18-18, 2024.
Japanese Article S-2. From the discovery of the heart effect of angiotensin II neonates-specific for infancy to a childhood heart failure therapeutic drug
川岸裕幸1)2), 中島岳郎3), Risa Ramadhiani4), 中田勉5), 冨田拓郎2), 諫田泰成1), 江本憲昭4), 山田充彦2)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 19-19, 2024.
Japanese Article S-3. Search of new kidney condition of a patient control molecules contributing to chronic kidney disease therapeutic drug development
尾花理徳
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 20-20, 2024.
Japanese Article YD-1. Compound X which was an extract of the natural product Japanese pepper improved cardiac function failed
高橋寧音1), 川瀬裕斗1), 平子裕太1), 鳴田竜也1), 船本雅文1)2), 砂川陽一1)2)3), 刀坂泰史1)2)3), 浜辺俊秀1)2)3), 小見山麻紀2), 長谷川浩二1)2), 森本達也1)2)3)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 24-24, 2024.
Japanese Article YD-2. BRG1 inhibitor PFI-3 inhibited heart contraction function aggravation in the pressure load heart failure model mouse
眞鍋智弘1), 上原渉1), 船本雅文1)2)4), 山本みずほ1), 砂川陽一1)2)3), 刀坂泰史1)2)3), 浜辺俊秀1)2)3), 川瀬裕斗1), 鳴田竜也1), 池田康将4), 長谷川浩二1)2), 森本達也1)2)3)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 25-25, 2024.
Japanese Article YD-3. The elevated blood pressure that is specific for a neovascularisation inhibitor raises the onset risk of aortic dissection
辻中海斗1)2), 石澤有紀1)3), 宮田晃志1), 吉岡俊彦1)2), 大峯航平1), 西穂香1), 近藤正輝1)2), 糸数柊人1), 宮田辰巳1), 新村貴博1)4), 佐藤真希1), 相澤風花1)2), 八木健太1)4), 中馬真幸5), 座間味義人6), 合田光寛1)2), 石澤啓介1)2)4)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 26-26, 2024.
Japanese Article YD-4. Pathophysiological role of the chymase for the cisplatin-induced acute renal failure
吉本将成1)2), 金徳男1), 左近上博司2), 高井真司1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 27-27, 2024.
Japanese Article YD-5. The vesicle derived from aging feeling fibroblasts out of the cells induces the automatic fuzzy of heart fibroblasts through expression of Ras homolog enriched in brain like-1 inhibition
藤岡友星, 大谷紘資, 兒玉朋子, 岡田宗善, 山脇英之
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 28-28, 2024.
English Article YD-6. NRDC in vascular smooth muscle cells controls vascular contraction and blood pressure via the regulation of calcium mobilization
Batbaatar Mend Amar1)3), Ohno Mikiko1), Kinoshita Takeshi2), Nishi Kiyoto1), Ikeda Shinya1), Nishi Eiichiro1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 29-29, 2024.
Japanese Article YD-7. The C-C chemokines receptor -2 block improves rat pulmonary hypertension and shows the synergy with the pulmonary vasodilator
坪谷尚季1), 澤田博文1), 三谷義英1), 大下裕法2), 武岡真美1), 大矢和伸1), 宮坂佳樹3), 伊藤弘将4), 淀谷典子1), 大橋啓之1), 丸山淳子5), 真下知士6), 岡本隆二4), 土肥薫4), 西村有平7), 丸山一男8), 平山雅浩1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 30-30, 2024.
Japanese Article YIA-1. Elucidation of the detailed sex differences formation mechanism of the renal function about pharmacokinetics
清水聡史1)2), Pornparn Kongpracha2), 杉本早穗1), 水野葵1), 宮坂政紀2), Pattama Wiriyasermkul2), 坂本多穗1), 児玉昌美1)2), 中井雄治3), 永森收志2), 黒川洵子1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 34-34, 2024.
Japanese Article YIA-2. The lack of fluid intake brings about sthenia and elevated blood pressure of the kidney sympathetic nervous activity through AT1 receptor
北田研人, 藤澤良秀, 西山成
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 35-35, 2024.
Japanese Article YIA-3. The effect that eEF2K inhibitor A484954 gives to hyperglycemia and high blood pressure in the type 2 diabetes model rat
兒玉朋子1), 亀島聡2), 大谷紘資1), 岡田宗善1), 山脇英之1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 36-36, 2024.
Japanese Article YIA-4. Prostaglandin D2 promotes the metastasis of cancer by inhibiting anticancer immunity
小林幸司1), 大森啓介2), 村田幸久1)2)3)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 37-37, 2024.
Japanese Article YIA-5. We maintain the activated state of the Wnt/β-catenin signal by increasing integrin-linked kinase, and TMEM182 inhibits the myocardium differentiation of human iPS cells
森原啓文1), 横江俊一1), 若林繋夫1)2), 高井真司1)3)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 38-38, 2024.
Japanese Article O-1. The anserine which was histidine-containing dipeptide inhibited the heart contraction ability drop of cardiac muscle cells enlargement and the pressure load model mouse
色川雄大1), 砂川陽一1)2)3), 山田美帆1), 片桐宇大1), 前川健也1), 清水聡史1)2), 刀坂泰史1)2)3), 浜辺俊秀1)2)3), 川瀬裕斗1), 鳴田竜也1), 船本雅文1)2), 清水果奈1)2), 浅川倫宏4), 長谷川浩二1)2), 森本達也1)2)3)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 42-42, 2024.
Japanese Article O-2. Heart rate control structure with the M16 metalloendopeptidase
大野美紀子1), 松浦博2), 西清人1), 糀谷泰彦3), 牧山武3), 池田真也1), 西英一郎1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 43-43, 2024.
Japanese Article O-3. Elucidation of Chinese medicine and the mechanism of action inhibiting doxorubicin cardiotoxicity
船本雅文1), 村松明美穂2), 今西正樹2), 土屋浩一郎2), 池田康将1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 44-44, 2024.
Japanese Article O-4. Effect of the mTOR inhibitor Everolimus on doxorubicin-induced apoptosis in cardiac muscle cells and the cancer cell
菅野秀一, 蓬田伸, 原明義
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 45-45, 2024.
Japanese Article O-5. Usefulness of the soluble guanylate cyclase activation medicine for the coronary spasm
田和正志, 中川恵輔, 大喜多守
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 46-46, 2024.
Japanese Article O-6. Bioactive adipose search to cause nasal congestion in allergic rhinitis
村田幸久1)2)3), 橘侑里1), 中村達朗1), 荒井美乃4), 曽根正好4), 小林幸司3), 永田奈々恵1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 47-47, 2024.
Japanese Article O-7. The effect that the sedative dexmedetomidine for humans and anesthetic medetomidine for the animal give for thrombogenesis
狩野泰輝, 菅沼由唯, 池本和久, 一瀬千穂, 近藤一直
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 48-48, 2024.
Japanese Article O-8. The myocardium-specific PRMT5 KO mouse shows a dilated cardiomyopathy-like symptom
鳴田竜也1), 刀坂泰史1)2)3), 砂川陽一1)2)3), 浜辺俊秀1)2)3), 長谷川浩二1)2), 森本達也1)2)3)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 52-52, 2024.
Japanese Article O-9. Effect of the CaMKII activation on atrial fibrillation-induced sthenia in the high fat diet load obese mice model
澤野達哉1), 三明淳一朗1), 岡村昌宏2), 友森匠也2), 今村武史1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 53-53, 2024.
Japanese Article O-10. Role of the aldosterone for the ventricular arrythmia induction in the pressure load bucardia
小原幸, 鳥羽裕恵, 中田徹男
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 54-54, 2024.
Japanese Article O-11. Skeletal muscle differentiation and the control that a cell fusion factor results in
冨田太一郎, 三上義礼, 大島大輔, 鄭有人, 赤羽悟美
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 55-55, 2024.
Japanese Article O-12. About protection of transcription factor NR4A1 for the vascular smooth muscle cell death by the extension stimulation in imitation of high blood pressure
趙晶, 中平毅一, 京谷陽司, 吉栖正典
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 56-56, 2024.
Japanese Article O-13. Effect of the soluble guanylate cyclase stimulant drug on ischemic acute renal failure
中川恵輔, 杉山美羽, 井上悠, 佐々木里真, 北條賢太郎, 田和正志, 大喜多守
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 57-57, 2024.
Japanese Article O-14. Elucidation of the pyruvate metabolism control structure by branched-chain amino acid metabolites
西清人1), 大野美紀子1), 西英一郎1), Tian Rong2)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 33: 58-58, 2024.
▲